中枢神経系治療の世界市場:タイプ別(神経変性、気分障害、統合失調症、自閉症、うつ病)、用途別(病院、診療所、家庭、その他)、地域別予測

◆英語タイトル:Global CNS Therapeutics Market Size study, by Type (Neurodegenerative, Mood Disorders, Schizophrenia, Autism, Depression), by Application (Hospital Use, Clinic Use, Household, Others) and Regional Forecasts 2018-2025
◆商品コード:BZW8D30
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2018年12月
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥610,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、中枢神経系治療の世界市場について調べ、中枢神経系治療の世界規模、市場動向、市場環境、タイプ別(神経変性、気分障害、統合失調症、自閉症、うつ病)分析、用途別(病院、診療所、家庭、その他)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer、Janseen Pharmaceuticals、Allergan、Lundbeck、Teva、Camber Pharmaceuticals、Zhejiang Haisen Pharmaceuticals、Jewim Pharmaceuticals、Cipla、Merck Sharp & Dohme Corp.、Eli Lilly、GlaxoSmithKline、Novartis、LUPIN 、ZYDUS PHARMSなどです。
・イントロダクション
・エグゼクティブサマリー
・中枢神経系治療の世界市場概要
・中枢神経系治療の世界市場環境
・中枢神経系治療の世界市場動向
・中枢神経系治療の世界市場規模
・中枢神経系治療の世界市場規模:タイプ別(神経変性、気分障害、統合失調症、自閉症、うつ病)
・中枢神経系治療の世界市場規模:用途別(病院、診療所、家庭、その他)
・中枢神経系治療の世界市場:地域別市場規模・分析
・中枢神経系治療の北米市場規模・予測
・中枢神経系治療のアメリカ市場規模・予測
・中枢神経系治療のヨーロッパ市場規模・予測
・中枢神経系治療のアジア市場規模・予測
・中枢神経系治療の日本市場規模・予測
・中枢神経系治療の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global CNS Therapeutics Market to reach USD 130 billion by 2025.

Global CNS Therapeutics Market valued approximately USD 82.3 billion in 2017 is anticipated to grow with a healthy growth rate of more than 5.93% over the forecast period 2018-2025. The major driving factor of global CNS Therapeutics market are rising cases of mental illness and increasing awareness regarding psychiatric disorders. In addition, expanding geriatric population and rising prevalence of lifestyle associated CNS disorders are some other major driving factors which boosting the market. However, one of the major restraining factor of CNS Therapeutics market is several side effects of CNS therapeutics such as weight gain, insomnia, lowered libido, tremors and agitation which hampers the market growth. It refers CNS disorders that effect the structure or function of the brain or spinal cord such as Parkinson’s, disease, epilepsy, Alzheimer disease, anxiety, depression and bipolar disorders. There are many key advantages of CNS therapeutic such as it has the benefit to high concentration in brain, it reduces systematic side effects, large drug distribution volume, it has flexible therapy protocol and it has consistent drug concentration. The major trend of global CNS therapeutics market is increase in adoption of new generation drugs. The regional analysis of Global CNS Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The major market player included in this report are:
• Pfizer
• Janseen Pharmaceuticals
• Allergan
• Lundbeck
• Teva
• Camber Pharmaceuticals
• Zhejiang Haisen Pharmaceuticals
• Jewim Pharmaceuticals
• Cipla
• Merck Sharp & Dohme Corp.
• Eli Lilly
• GlaxoSmithKline
• Novartis
• LUPIN
• ZYDUS PHARMS

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

 Neurodegenerative
 Mood Disorders
 Schizophrenia
 Autism
 Depression

By Application:

 Hospital Use
 Clinic Use
 Household
 Others

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global CNS Therapeutics Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. CNS Therapeutics Market, by Type, 2015-2025 (USD Billion)
1.3.2. CNS Therapeutics Market, by Application, 2015-2025 (USD Billion)
1.3.3. CNS Therapeutics Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. CNS Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. CNS Therapeutics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. CNS Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. CNS Therapeutics Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. CNS Therapeutics Market, Sub Segment Analysis
5.4.1. Neurodegenerative Diseases
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Mood Disorders
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. Schizophrenia
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.4. Autism
5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.5. Depression
5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. CNS Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. CNS Therapeutics Market, Sub Segment Analysis
6.4.1. Hospital Use
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Clinic Use
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Household
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Other
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. CNS Therapeutics Market, by Regional Analysis
7.1. CNS Therapeutics Market, Regional Market Snapshot (2015-2025)
7.2. North America CNS Therapeutics Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe CNS Therapeutics Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia CNS Therapeutics Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America CNS Therapeutics Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Janseen Pharmaceuticals
8.3.3. Allergan
8.3.4. Lundbeck
8.3.5. Teva
8.3.6. Camber Pharmaceuticals
8.3.7. Zhejiang Haisen Pharmaceuticals
8.3.8. Jewim Pharmaceuticals
8.3.9. Cipla
8.3.10. Merck Sharp & Dohme Corp.
8.3.11. Eli Lilly
8.3.12. GlaxoSmithKline
8.3.13. Novartis
8.3.14. LUPIN
8.3.15. ZYDUS PHARMS
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF CNS THERAPEUTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF CNS THERAPEUTICS MARKET
TABLE 3. CNS THERAPEUTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8. CNS THERAPEUTICS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. CNS THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. CNS THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW CNS THERAPEUTICS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. CNS THERAPEUTICS MARKET, RESEARCH METHODOLOGY
FIG 2. CNS THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. CNS THERAPEUTICS MARKET, KEY TRENDS 2016
FIG 5. CNS THERAPEUTICS MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. CNS THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. CNS THERAPEUTICS MARKET, PEST ANALYSIS
FIG 8. CNS THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. CNS THERAPEUTICS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. CNS THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA CNS THERAPEUTICS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE CNS THERAPEUTICS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC CNS THERAPEUTICS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA CNS THERAPEUTICS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36. CNS THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Pfizer、Janseen Pharmaceuticals、Allergan、Lundbeck、Teva、Camber Pharmaceuticals、Zhejiang Haisen Pharmaceuticals、Jewim Pharmaceuticals、Cipla、Merck Sharp & Dohme Corp.、Eli Lilly、GlaxoSmithKline、Novartis、LUPIN 、ZYDUS PHARMS

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[中枢神経系治療の世界市場:タイプ別(神経変性、気分障害、統合失調症、自閉症、うつ病)、用途別(病院、診療所、家庭、その他)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆